Enocitabine

Enocitabine
Systematic (IUPAC) name
N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]docosanamide
Clinical data
AHFS/Drugs.com International Drug Names
  • ℞ (Prescription only)
IV
Identifiers
55726-47-1 Yes
None
PubChem CID 71734
ChemSpider 64778 
UNII 9YVR68W306 Yes
KEGG D01633 Yes
Chemical data
Formula C31H55N3O6
565.78 g/mol
  (what is this?)  (verify)

Enocitabine (INN, marketed under the brand name Sunrabin) is a nucleoside analog used as chemotherapy.

Sunrabin contains the emulsifier HCO-60, which can cause allergic reactions.[1]

References

  1. ↑ Tatetsu H, Asou N, Nakamura M et al. (July 2003). "[Allergic reaction against an emulsifier, HCO-60, contained in multamin and enocitabine]". Rinsho Ketsueki (in Japanese) 44 (7): 471–3. PMID 12931567.